GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (WBO:EVT) » Definitions » Pre-Tax Income

Evotec SE (WBO:EVT) Pre-Tax Income : €-74.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Evotec SE Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Evotec SE's pretax income for the three months ended in Dec. 2023 was €-24.0 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was €-74.4 Mil. Evotec SE's pretax margin was -11.93%.

During the past 13 years, Evotec SE's highest Pretax Margin was 38.34%. The lowest was -20.49%. And the median was 9.74%.


Evotec SE Pre-Tax Income Historical Data

The historical data trend for Evotec SE's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Pre-Tax Income Chart

Evotec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.68 25.84 236.98 -153.96 -80.59

Evotec SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.36 -17.52 -20.44 -29.92 -24.03

Competitive Comparison of Evotec SE's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Evotec SE's Pre-Tax Income falls into.



Evotec SE Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Evotec SE's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-42.497+-35.62+-11.739+9.263+-1.4210854715202E-14
=-80.6

Evotec SE's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-11.668+-10.279+-3.181+1.103+0
=-24.0

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-74.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evotec SE  (WBO:EVT) Pre-Tax Income Explanation

Evotec SE's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-24.025/201.313
=-11.93%

During the past 13 years, Evotec SE's highest Pretax Margin was 38.34%. The lowest was -20.49%. And the median was 9.74%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evotec SE Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Evotec SE's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE (WBO:EVT) Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Evotec SE (WBO:EVT) Headlines